The Strategy-to-Impact Partner for Life Sciences Companies
Prescient's analysis shows that launch archetype and therapy area are critical variables in shaping launch uptake and that different combinations create distinctly different must-win moments.
A first-in-class rare disease launch may need to build the system that identifies and refers patients. A biomarker-led oncology launch may depend on making testing happen early enough to influence treatment. In immunology, maintaining advantage may require a continuously evolving evidence story. In cardiovascular disease, the challenge may be finding and activating a large eligible but untreated population.
The implication is simple: launch excellence needs to become Precision Launch excellence.
From building the right foundations to optimizing in-market performance, we focus every stage of the launch journey on the specific moments, decisions and capabilities that will matter most for your asset:
Launch excellence starts with strong foundations, but not every launch requires the same capabilities, governance or level of investment.
We benchmark your organization against our Seven Levers of Launch Excellence, then overlay your therapy area, launch archetype and market context to identify the capabilities that matter most for your launch.
This focuses time, resources and capability-building where they will have the greatest impact, rather than pursuing readiness everywhere.
We define your Launch Archetype and identify the specific inflection points, uptake drivers and strategic decisions that will disproportionately shape performance.
Using relevant launch analogues, therapy-area insight and proprietary benchmarking, we identify your must-win moments and translate them into a Precision Launch Blueprint.
This gives you a differentiated launch strategy that focuses investment and leadership attention on the few things most likely to determine success.
We translate your Precision Launch Strategy into a Living Launch Plan built around the critical actions, dependencies and strategic levers required to win your specific launch scenario.
Cross-functional priorities across Commercial, Medical and Value, Pricing & Access are connected around the same must-wins, creating a clear red thread from strategy through execution.
The plan is deliberately not static. We identify the assumptions it depends on, the uncertainties that could change it and the signals teams need to monitor.
Precision readiness asks whether the conditions that matter most for this launch are in place.
We pressure-test readiness against your must-win moments and highest-risk assumptions, using scenario thinking and decision rehearsal to expose vulnerabilities before the market does.
Where uncertainty remains, we define observable triggers and rehearse the decisions required.
You gain greater leadership confidence in the decisions that carry the greatest consequence, and a team that is fully prepared to respond.
Launch doesn't end when the plan meets the market. We continuously connect performance against must-win moments with leading indicators, competitive intelligence, external signals and scenario triggers to understand whether the assumptions behind the strategy remain true.
Through a Living Launch Command Centre developed by our Competitive Strategy practice, we help teams distinguish signal from noise, rapidly capture learning across markets and adapt strategy, investment and execution as conditions evolve.
The life sciences landscape is full of complexity, but you don't have to navigate it alone. As your strategy-to-impact partner, we are here to help you see further, go deeper and deliver impact where it counts.
Connect with our Experts